Please ensure Javascript is enabled for purposes of website accessibility

Why Bionano Genomics Stock Is Down Today

By Joe Tenebruso - Jan 20, 2021 at 12:50PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The biotech's stock sales are alarming investors.

What happened

Shares of Bionano Genomics (BNGO 5.41%) fell on Wednesday after the genome-analysis company announced the pricing of its public stock offering. As of 12:30 p.m. EST, Bionano's stock price was down 13%.

So what

Bionano expects to raise roughly $200 million via the sale of 33,333,350 shares of common stock at a price of $6 per share. It also gave underwriters the option to purchase (and subsequently sell) an additional 5 million shares at the same price. Bionano's stock sale is expected to close on Jan. 22.

A downwardly sloping stock chart.

Bionano Genomics' stock plunged on Wednesday. Image source: Getty Images.

The $6 public offering price was well below Bionano's closing price of $9.14 on Tuesday. The biotech's decision to sell stock more than 30% below its market price likely led some investors to take profits off the table by selling their own shares.

Now what

Despite today's decline, Bionano's stock price is up a staggering 1,370% in the past month. Investors have bid up the biotech's shares after a series of presentations by doctors and scientists highlighted the capabilities of Bionano's Saphyr optical genome mapping (OGM) system.  

With its share price surging, Bionano's management has chosen to raise a total of approximately $300 million via stock sales in recent weeks.

Bionano is now on far more solid ground financially. And if Saphyr can deliver on its promise to improve healthcare outcomes for people with a host of genetic diseases, Bionano could deliver more gains to investors in the months and years ahead.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Bionano Genomics, Inc. Stock Quote
Bionano Genomics, Inc.
BNGO
$1.56 (5.41%) $0.08

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
332%
 
S&P 500 Returns
118%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.